GlassScriptPhysician profile
Alexandre Rasouli
NPI 1528252905
$19,947.20
in general payments reported to CMS, 2019-2025
19 companies · $3,046 in 2025
The $3,046 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $755 · 2021: $580 · 2022: $751 · 2023: $1,758 · 2024: $238 · 2025: $3,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,750 · Travel and Lodging: $1,389 · Food and Beverage: $903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,750.00 |
| Travel and Lodging | $1,389.42 |
| Food and Beverage | $902.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $8,558.77 | 2019 | |
| Medtronic USA, INC. | $3,127.97 | 2019-2020 | |
| Centinel Spine, LLC | $2,750.00 | 2025 | Prodisc L |
| Nuvasive, INC. | $2,604.95 | 2019-2023 | Xlif |
| Globus Medical, INC. | $1,623.74 | 2023-2025 | Excelsiusgps Robotic Navigation System, Sustain Medium / Preserve Acdf, Xlif |
| Depuy Synthes Sales INC. | $510.80 | 2019-2022 | |
| Boston Scientific Corporation | $142.44 | 2021-2025 | Intracept |
| Carlsmed, INC. | $135.37 | 2025 | Aprevo |
| Kyocera Medical Technologies, INC. | $111.91 | 2019-2024 | |
| Providence Medical Technology, INC. | $78.31 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $67.84 | 2025 | |
| Augmedics INC. | $66.69 | 2022 | |
| Alphatec Spine, INC | $43.57 | 2025 | Other - Miscellaneous |
| Baxter Healthcare | $43.52 | 2024 | Floseal |
| Pacira Pharmaceuticals Incorporated | $27.31 | 2024 | Exparel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $19.12 | 2023 | Barricaid Acd (Annular Closure Device) |
| Si-Bone, INC. | $18.66 | 2023 | |
| Abbott Laboratories | $16.23 | 2023 | Eterna |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Rasouli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.